Navigation Links
[video] Dr. Tony Milici, Chairman and CEO of GeneThera, Inc., Discusses Worldwide Rights to E.Coli Vaccine on WallSt.net's 3-Minute Press Show
Date:10/8/2008

WHEAT RIDGE, Colo., Oct. 8 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), a molecular biotechnology company, today announced that the company's Chairman and CEO, Dr. Tony Milici, is featured in an exclusive interview on WallSt.net's 3-Minute Press Show.

The interview gives viewers an overview of the company, and the significance of the company's latest press release.

To view the clip in its entirety, visit: http://www.tv.wallst.net/r/3-minute-press/A-Milici-GTHR-PK/285/1134

Ask Dr. Tony Milici a question, post a comment on his personal page, and join his financial social network today at: http://my.wallst.net/A-Milici-GTHR-PK

About GeneThera, Inc.:

GeneThera, Inc. is a molecular biotechnology company located in Wheat Ridge, CO. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the health-care industry. The Company's proprietary diagnostic solution is based on a genetic expression system, GES, a protocol designed to function on a highly automated Fluorogenic PCR platform. This platform enables GeneThera to offer tests that are presently not available from other technologies. The GES is designed for a host of individual diseases, the current priority being Mad Cow disease, Chronic Wasting Disease, E.Coli 0157:H7 and Johne's disease, all diseases affecting cattle worldwide.

About WallStreet Direct, Inc.

WallStreet Direct, Inc. operates WallSt.net (http://www.wallst.net), a leading source of up-to-the-minute business news, comprehensive financial tools and original multimedia content for the investment community. In addition to WallSt.net, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net), an online hub for business podcasts from well-known business news personalities and publishers, and WallStTV (http://tv.wallst.net), a hub for business and finance video content. We have received two hundred eighty dollars from GeneThera, Inc. for the dissemination of this press release. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.php.

Contact:

WallStreet Direct, Inc.

800-4-WALLST


'/>"/>
SOURCE GeneThera, Inc.; WallStreet Direct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. [video] Edward Spink, CEO of TurboSonic Technologies, Inc. Discusses Contract With Biofuel Producer in Exclusive Interview on WallSt.nets 3-Minute Press Show
2. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
3. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
4. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
5. Chairman & CEO of KIWA, Li Wei, Interviewed by Phoenix Satellite TV
6. Agendia BV Appoints Mr. Hessel Lindenbergh as Chairman of its Supervisory Board
7. OmniSonics Appoints J. Daniel Cole Chairman of the Board
8. Yves Lionel Assant is New Chairman of Gerresheimers Supervisory Board
9. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
10. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
11. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... PALM BEACH, Florida , March 22, 2017 ... ... management for various cancer conditions are being pressured as of ... pain therapy for cancer pain management has a dramatic impact ... ramp up research and development activities for identifying new forms ...
(Date:3/22/2017)... 2017   VWR (NASDAQ: VWR), ... and service solutions to laboratory and production ... EPL Archives, Inc., an international biorepository services ... regulated product research, development and commercialization lifecycle ... ancillary services. EPL Archives is widely recognized ...
(Date:3/22/2017)... Ca (PRWEB) , ... March 21, 2017 , ... ... clearance of biologics. To acquire information on the desired increase and/or decrease in ... biopharmaceutical industry for rapid N-glycosylation profiling of therapeutic antibodies. , To meet ...
Breaking Biology Technology:
(Date:3/13/2017)... 13, 2017 Future of security: Biometric Face Matching software  ... ... DERMALOGs Face Matching enables to match face pictures against each other ... identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric Face Matching on the ...
(Date:3/7/2017)...   HireVue , the leading provider of video ... best talent, faster, today announced the additions of ... Diana Kucer as Chief Marketing Officer (CMO). ... poised to drive continued growth in the company,s new ... record bookings in 2017. "Companies worldwide turn ...
(Date:3/2/2017)... Who risk to be deprived of its ... report: https://www.reportbuyer.com/product/4313699/ WILL APPLE AND SAMSUNG ... Fingerprint sensors using capacitive technology represent a fast growing ... forecasts an increase of 360% of the number of ... fingerprint sensor market between 2014 and 2017 (source : ...
Breaking Biology News(10 mins):